• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TSI
Click for more information
0.00% 4.0¢

TOP SHELF INTERNATIONAL HOLDINGS LTD - Charts / Financials

Market Cap $13.00M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Beverages - Wineries & Distilleries

Top Shelf International Holdings Limited is an Australia-based distiller and marketer of... Top Shelf International Holdings Limited is an Australia-based distiller and marketer of premium Australian spirits. The Company’s brands are NED Australian Whisky and Grainshaker Hand Made Australian Vodka. The Company has expertise in the development and production of distilled spirits, undertakes a significant level of research and development and operates modern fermentation, distillation and packaging facilities in Campbellfield, Victoria. The Company also provides canning, bottling, and packaging services to a range of customers. NED is a whisky in Australia that comes in both bottle and ready-to-serve formats. The Company’s maturation facilities and bond stores are located in Somerton, Victoria, and house oak vats and barrels for the storage of whisky inventory. The Company’s Agave spirit farm is situated in the Whitsundays region of Queensland.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 04/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Mr. Trent Fraser Chief Executive Officer
Mr. Kim Graves Joint Company Secretary
Mr. Harry Pratt Joint Company Secretary
Mr. Julian Davidson Independent Non-Executive Chairman of the Board
Mr. Adem Karafili Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.00M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Buxton projects new graphite province discovery at WA Narryer play Buxton Resources Ltd has reported strong drilling results together with remodelling data from its Narryer project in Western Australia
Neurotech knocked back by FDA as agency declares target condition not rare enough for special status Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.